Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.43 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10538290 | 0.97 | CA1 (0.42) | CA1CA12CA9CA2CA14 | |
| SCHEMBL27564460 | 0.97 | CA1 (0.42) | CA1CA12CA9CA2CA14 | |
| SCHEMBL5252089 | 0.92 | CA1 (0.42) | CA1CA12CA9CA2CA14 | |
| SCHEMBL28620949 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 | |
| SCHEMBL7026899 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 | |
| SCHEMBL8211598 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 | |
| SCHEMBL5253616 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 | |
| SCHEMBL28640485 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 | |
| SCHEMBL28621286 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 | |
| SCHEMBL28635214 | 0.90 | DNM1 (0.46) | CA1CA12CA9CA2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6225347-B1 | FOR LOWERING BLOOD PRESSURE, INHIBITING PLATELET AGGREGATION, FOR LUTEOLYTIC EFFECT, HEALING ULCER, INHIBITING GASTRIC ACID SECRETION, AS CYTOPROTECTIVE AGENT | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-05-01 | — | — | US | claimed |
| US-5891910-A | 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | claimed |
| US-4140684-A | FOR POLYESTERS, POLYAMIDES, AND CELLULOSE ACETATES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1979-02-20 | — | — | US | claimed |
| US-4017477-A | 3-Halogeno-6-hydroxy-pyridone-(2) azo dyestuffs | CIBA-GEIGY AG (CH) | 1977-04-12 | — | — | US | claimed |
| US-4011208-A | 3-CYANO OR ACYL-4-ARYL-5-ARYLAZO-6-HYDROXYPYRIDONE-2 DYES | SANDOZ LTD. (CH) | 1977-03-08 | — | — | US | claimed |
| US-12606464-B2 | Membrane separation method | KURITA WATER INDUSTRIES LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-4635610-A1 | MEMBRANE TREATMENT METHOD AND BIOFOULING SUPPRESSION METHOD | Kurita Water Industries Ltd. (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-12303833-B2 | Reverse osmosis membrane treatment system and reverse osmosis membrane treatment method | ORGANO CORPORATION (JP) | 2025-05-20 | — | — | US | disclosed |
| US-12083480-B2 | Method for controlling slime in reverse osmosis membrane apparatus | KURITA WATER INDUSTRIES LTD. (JP) | 2024-09-10 | — | — | US | disclosed |
| WO-2024128050-A1 | MEMBRANE TREATMENT METHOD AND BIOFOULING SUPPRESSION METHOD | 栗田工業株式会社 | 2024-06-20 | — | — | WO | disclosed |
| US-20240083779-A1 | METHOD FOR OPERATING REVERSE OSMOSIS MEMBRANE DEVICE, A SLIME CONTROL METHOD, AND A WATER TREATMENT DEVICE | KURITA WATER INDUSTRIES LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11916195-B2 | Electrolyte solution, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| US-4105792-A | OXYTOCICS, ABORTION INDUCTION | SCHERING AKTIENGESELLSCHAFT (DE) | 1978-08-08 | — | — | US | disclosed |
| US-4038410-A | ANTI-PROTOZOAN AGENTS | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-07-26 | — | — | US | disclosed |
| US-4011208-A | 3-CYANO OR ACYL-4-ARYL-5-ARYLAZO-6-HYDROXYPYRIDONE-2 DYES | SANDOZ LTD. (CH) | 1977-03-08 | — | — | US | disclosed |
| US-4011314-A | FOR TREATING ESTROGEN DEFICIENCY | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-03-08 | — | — | US | disclosed |
| US-3979378-A | Water-soluble azo dyes having a substituted 2-hydroxypyridone (6) coupling component | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-09-07 | — | — | US | disclosed |
| US-3951958-A | VAGINOTROPIC | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | disclosed |
| US-3951959-A | VAGINOTROPIC | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | disclosed |
| US-3943120-A | WATER INSOLUBLE | CIBA-GEIGY AG (CH) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606464-B2 | Membrane separation method | CLIC4, DUOX2, CLIC1 | CA1 359/4885CA12 407/4885CA9 447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.